SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001104659-23-110477
Filing Date
2023-10-20
Accepted
2023-10-20 16:06:14
Documents
50

Document Format Files

Seq Description Document Type Size
1 S-1 tm2321493-8_s1.htm S-1 3142184
2 EXHIBIT 3.1 tm2321493d9_ex3-1.htm EX-3.1 129208
3 EXHIBIT 3.2 tm2321493d9_ex3-2.htm EX-3.2 44951
4 EXHIBIT 3.3 tm2321493d9_ex3-3.htm EX-3.3 160051
5 EXHIBIT 3.4 tm2321493d9_ex3-4.htm EX-3.4 156102
6 EXHIBIT 4.1 tm2321493d9_ex4-1.htm EX-4.1 19687
7 EXHIBIT 4.2 tm2321493d9_ex4-2.htm EX-4.2 15512
8 EXHIBIT 4.3 tm2321493d9_ex4-3.htm EX-4.3 13257
9 EXHIBIT 4.4 tm2321493d9_ex4-4.htm EX-4.4 13781
10 EXHIBIT 4.5 tm2321493d9_ex4-5.htm EX-4.5 215519
11 EXHIBIT 10.1 tm2321493d9_ex10-1.htm EX-10.1 219039
12 EXHIBIT 10.2 tm2321493d9_ex10-2.htm EX-10.2 360041
13 EXHIBIT 10.3 tm2321493d9_ex10-3.htm EX-10.3 80096
14 EXHIBIT 10.4 tm2321493d9_ex10-4.htm EX-10.4 77926
15 EXHIBIT 10.5 tm2321493d9_ex10-5.htm EX-10.5 30494
16 EXHIBIT 10.6 tm2321493d9_ex10-6.htm EX-10.6 95836
17 EXHIBIT 10.7 tm2321493d9_ex10-7.htm EX-10.7 153490
18 EXHIBIT 10.8 tm2321493d9_ex10-8.htm EX-10.8 63748
19 EXHIBIT 10.9 tm2321493d9_ex10-9.htm EX-10.9 88795
20 EXHIBIT 10.13 tm2321493d9_ex10-13.htm EX-10.13 19696
21 EXHIBIT 10.14 tm2321493d9_ex10-14.htm EX-10.14 93530
22 EXHIBIT 23.1 tm2321493d9_ex23-1.htm EX-23.1 1864
23 EX-FILING FEES tm2321493d9_ex-filingfees.htm EX-FILING FEES 14806
24 GRAPHIC bc_plasma-4c.jpg GRAPHIC 48472
25 GRAPHIC fc_fig01invea-4c.jpg GRAPHIC 123249
26 GRAPHIC fc_fig03dysreg-4c.jpg GRAPHIC 100336
27 GRAPHIC fc_fig04cellbio-4c.jpg GRAPHIC 87512
28 GRAPHIC fc_fig05inflama-4c.jpg GRAPHIC 73109
29 GRAPHIC fc_fig06mediator-4c.jpg GRAPHIC 121937
30 GRAPHIC fc_imidsubmet-4c.jpg GRAPHIC 96436
31 GRAPHIC fc_lpsatpmousemodel-4c.jpg GRAPHIC 90649
32 GRAPHIC fc_pipelinee-4c.jpg GRAPHIC 81570
33 GRAPHIC fc_triggers-4c.jpg GRAPHIC 91384
34 GRAPHIC lc_fig08primary-bw.jpg GRAPHIC 25358
35 GRAPHIC lc_fig09igascor01-bw.jpg GRAPHIC 17748
36 GRAPHIC lc_fig09igascor02-bw.jpg GRAPHIC 17628
37 GRAPHIC lc_fig12plasma-bw.jpg GRAPHIC 78478
38 GRAPHIC lc_fig14inva8001-bw.jpg GRAPHIC 56455
39 GRAPHIC lg_inveatherapeutics-4c.jpg GRAPHIC 11997
40 GRAPHIC ph_intactskin-4c.jpg GRAPHIC 420748
41 GRAPHIC tb_adseverity-4c.jpg GRAPHIC 26690
42 GRAPHIC tb_assesment-4c.jpg GRAPHIC 58841
43 GRAPHIC tb_enzyme-4c.jpg GRAPHIC 31243
44 GRAPHIC tb_mean-bw.jpg GRAPHIC 60519
45 GRAPHIC tb_placebo-4c.jpg GRAPHIC 47029
46 GRAPHIC tb_report-4c.jpg GRAPHIC 167503
47 GRAPHIC tb_system-4c.jpg GRAPHIC 139705
48 GRAPHIC tb_system01-4c.jpg GRAPHIC 125998
49 GRAPHIC tb_system02-4c.jpg GRAPHIC 196534
50 GRAPHIC tbl_majortheraoeutic-4c.jpg GRAPHIC 281569
  Complete submission text file 0001104659-23-110477.txt   8879051
Mailing Address 2614 BOSTON POST ROAD, #33A GUILFORD CT 06437
Business Address 2614 BOSTON POST ROAD, #33A GUILFORD CT 06437 203-204-6363
Invea Therapeutics, Inc (Filer) CIK: 0001906425 (see all company filings)

IRS No.: 873198325 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-275109 | Film No.: 231337228
SIC: 2834 Pharmaceutical Preparations